Literature DB >> 1928336

Elevated skeletal muscle glucose transporter levels in exercise-trained middle-aged men.

J A Houmard1, P C Egan, P D Neufer, J E Friedman, W S Wheeler, R G Israel, G L Dohm.   

Abstract

Exercise training has been proposed to improve whole body insulin sensitivity through a postreceptor adaptation in skeletal muscle. This study examined if levels of the insulin-responsive muscle glucose transporter protein (GLUT-4) were associated with improved insulin sensitivity in trained vs. sedentary middle-aged individuals. Muscle GLUT-4 levels and oral glucose tolerance test (OGTT) responses were obtained in age-matched trained and sedentary men (n = 11). Plasma insulin levels during the OGTT were significantly lower (P less than 0.01) in the trained men, whereas no differences were seen in plasma glucose responses. GLUT-4 protein content was approximately twofold higher in the trained men (2.41 +/- 0.17 vs. 1.36 +/- 0.11 micrograms standard, P less than 0.001). OGTT responses and GLUT-4 levels were not altered 15-18 h after a standard exercise bout in six representative sedentary subjects. These data suggest that GLUT-4 levels are increased in conjunction with insulin sensitivity in chronically exercise-trained middle-aged men. This finding suggests a possible mechanism for the improved insulin sensitivity observed with exercise training in humans.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1928336     DOI: 10.1152/ajpendo.1991.261.4.E437

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  22 in total

Review 1.  Role of plasma membrane transporters in muscle metabolism.

Authors:  A Zorzano; C Fandos; M Palacín
Journal:  Biochem J       Date:  2000-08-01       Impact factor: 3.857

Review 2.  The exercise-induced growth hormone response in athletes.

Authors:  Richard J Godfrey; Zahra Madgwick; Gregory P Whyte
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

3.  Association of physical activity with muscular strength and fat-free mass in adolescents: the HELENA study.

Authors:  Diego Moliner-Urdiales; Francisco B Ortega; Germán Vicente-Rodriguez; Juan P Rey-Lopez; Luis Gracia-Marco; Kurt Widhalm; Michael Sjöström; Luis A Moreno; Manuel J Castillo; Jonatan R Ruiz
Journal:  Eur J Appl Physiol       Date:  2010-04-07       Impact factor: 3.078

Review 4.  Facilitative glucose transporters: regulatory mechanisms and dysregulation in diabetes.

Authors:  B B Kahn
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

Review 5.  Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training.

Authors:  Christian K Roberts; Andrea L Hevener; R James Barnard
Journal:  Compr Physiol       Date:  2013-01       Impact factor: 9.090

6.  Decreased physical fitness in borderline glucose tolerance men.

Authors:  Y Higaki; N Shono; M Nishizumi
Journal:  Environ Health Prev Med       Date:  1998-01       Impact factor: 3.674

Review 7.  Effects of exercise training on abdominal obesity and related metabolic complications.

Authors:  B Buemann; A Tremblay
Journal:  Sports Med       Date:  1996-03       Impact factor: 11.136

8.  Mechanism of enhanced insulin sensitivity in athletes. Increased blood flow, muscle glucose transport protein (GLUT-4) concentration, and glycogen synthase activity.

Authors:  P Ebeling; R Bourey; L Koranyi; J A Tuominen; L C Groop; J Henriksson; M Mueckler; A Sovijärvi; V A Koivisto
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

9.  GLUT 4 and insulin receptor binding and kinase activity in trained human muscle.

Authors:  F Dela; A Handberg; K J Mikines; J Vinten; H Galbo
Journal:  J Physiol       Date:  1993-09       Impact factor: 5.182

10.  Extremely short duration high intensity interval training substantially improves insulin action in young healthy males.

Authors:  John A Babraj; Niels B J Vollaard; Cameron Keast; Fergus M Guppy; Greg Cottrell; James A Timmons
Journal:  BMC Endocr Disord       Date:  2009-01-28       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.